AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Gemcitabine in South Africa
6 products registered with SAHPRA — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GEMCITABINE 200 mg/2 ml RTU ACCORD | 56/26/0961 | Accord Healthcare (Pty) Ltd | active | 16 Jul 2029 |
| GEMCITABINE 1 000 mg/10 ml RTU ACCORD | 56/26/0962 | Accord Healthcare (Pty) Ltd | active | 16 Jul 2029 |
| GEMCITABINE 1 500 mg/15 ml RTU ACCORD | 56/26/0963 | Accord Healthcare (Pty) Ltd | active | 16 Jul 2029 |
| GEMCITABINE 2 000 mg/20 ml RTU ACCORD | 56/26/0964 | Accord Healthcare (Pty) Ltd | active | 16 Jul 2029 |
| CYTIGEM 200 mg | 42/26/0089 | Eurolab (Pty) Ltd | active | 1 Jan 1900 |
| CYTIGEM 1 g | 42/26/0902 | Eurolab (Pty) Ltd | active | 1 Jan 1900 |
Gemcitabine — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Gemcitabine, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Gemcitabine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.